Carol I. Geppert
Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)University Hospital of Bern(CH)Universitätsklinikum Erlangen(DE)Comprehensive Cancer Center Erlangen(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Cervical Cancer and HPV Research, Ferroptosis and cancer prognosis, Urinary and Genital Oncology Studies
Most-Cited Works
- → Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab(2018)102 cited
- → Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study(2018)74 cited
- → NFATc1 Promotes Antitumoral Effector Functions and Memory CD8+ T-cell Differentiation during Non–Small Cell Lung Cancer Development(2018)63 cited
- → Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy(2020)58 cited
- → High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma(2018)45 cited